Skip to content
    +ND Capital logo

    +ND Capital

    Woodside, California, United StatesFounded 2002

    +ND Capital (formerly NanoDimension) is a venture capital firm founded in 2002 that invests in disruptive technologies across the life, physical, and data sciences, focusing on opportunities driven by scientific convergence. The firm is headquartered in Woodside, California with offices in Switzerland.

    48% of their portfolio is in Biotech & Life Sciences. Deal activity decreased year-over-year (1 deals in the last 12 months vs 3 prior). Average disclosed round size is $56.5M (across 17 rounds with reported amounts).

    Find people at +ND Capital on Goldilocks AI

    Portfolio

    17

    Fund Size

    $800M

    Top Stage

    Series A

    Last 12 Mo

    2

    Team

    Alison Palmer

    Alison Palmer

    Vice President of the General Partner

    Jonathan Nicholson

    Jonathan Nicholson

    Executive Director of the General Partner

    Richard Coles

    Richard Coles

    Director of the General Partner

    Eric Moessinger

    Eric Moessinger

    Partner

    Klaus Dugi

    Klaus Dugi

    Chief Medical Advisor & Venture Partner

    Kostas Kaloulis

    Kostas Kaloulis

    Venture Partner

    Luc Bauer

    Luc Bauer

    Venture Partner

    Peter Van Vlasselaer

    Peter Van Vlasselaer

    Venture Partner

    Ryan Schubert

    Ryan Schubert

    Venture Partner

    Kirill Kuzmichev

    Kirill Kuzmichev

    Principal

    Aymeric Sallin

    Aymeric Sallin

    Founder & Chief Executive Officer

    CO

    Cathleen O’Connor

    Executive Assistant

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    21 investments
    CompanyRoundAmountDate
    SPARK Microsystems logoSPARK MicrosystemsSeries BMar 2026
    Lightcast Bio logoLightcast BioUnknown$27MJan 2026
    Visby Medical logoVisby MedicalGrowth$55MJun 2025
    Constructive Bio logoConstructive BioSeries A$58MSep 2024
    Vandria logoVandriaSeries AAug 2024
    Lightcast Discovery logoLightcast DiscoverySeries B$49MAug 2023
    Lightcast logoLightcastUnknown$38MAug 2023
    Lightcast Bio logoLightcast BioSeries B$38MJan 2023
    Visby Medical logoVisby MedicalSeries E$135MJun 2022
    Cytoki Pharma logoCytoki PharmaSeries A$45MMay 2021
    Sorbet logoSorbetSeed$6MApr 2021
    Cytoki Pharma logoCytoki PharmaSeries A$45MJan 2021
    IIonPathSeries B$18MSep 2020
    SiMa.ai logoSiMa.aiSeries A$30MMay 2020
    AAltitude Trampoline ParkUnknownDec 2018
    SQZ Biotech logoSQZ BiotechSeries C$72MAug 2018
    DemandScience logoDemandScienceUnknown
    AiRNA logoAiRNASeries B$155M
    AiRNA logoAiRNASeries A$60M
    Haya Therapeutics logoHaya TherapeuticsSeries A$65M
    VVisby Medical, Inc.Series E$65M

    Top Co-Investors

    Last updated: 9 September 2026